Actionable news
All posts from Actionable news
Actionable news in GSK: GLAXOSMITHKLINE PLC,

GlaxoSmithKline's (GSK) CEO Andrew Witty on Q3 2015 Results - Earnings Call Transcript


Good day, ladies and gentlemen, and welcome to the GSK Investment Analysts Call to 15 Q3 2015 Results Call. My name is Brett and I am the call manager. [Operator Instructions] I would like to advise all parties today's conference is being recorded.

And now I would like to hand the call over to Sir Andrew Witty.

Andrew Witty - Chief Executive Officer

Thank you very much. Good afternoon, everybody, and thanks for joining this Q3 2015 results call. We've made further progress during this quarter to deliver the benefits of our recent transaction with Novartis and successfully execute our strategy. Our integration and restructuring programs are on track and sales are benefiting from recent new product introductions and those products recently acquired. All of this is providing us with confidence in our ability to meet our guidance for 2015 and for a return to significant earnings growth in 2016.

For the quarter, group sales were up 11% on a reported basis and 5% on a pro forma basis, both at CER. Earnings per share for the quarter was 23 pence at CER, and reflected a decline of 13%. The decline reflects the short-term dilution...